Pharmaceutical Raw Materials
Veterinary API
Antiallergic Drugs
Hormones and Endocrine Drugs
Drug Metabolism
Pharmaceutical Intermediates
Synthetic Anti Infective Drugs
Specialty Drugs
Vitamins and Minerals Medicines
Feed Drug Additive
Antineoplastic Agents
Nervous System Drugs
Respiratory Drugs
Diagnostic Agents
Anti Stress Drugs
Antipyretic Analgesics
Antiparasitic Drugs
Circulatory System Drugs
Biochemicals
Blood System Drugs
Immune System Medication
Pharmaceutical Excipients
Fluid, Electrolyte, and Acid-Base Balance
Urinary System Drugs
Antibiotics
Anesthetic Agents
Inhibitors
Other Chemical Drugs
Digestive System Drugs
CAS:23873-85-0
Molecular Formula:C24H34O4
Alias
More Information
Proligestonum; Proligestona; Proligestone[Ban:Inn]; Proligestonum [Inn-Latin]
Brief Introduction
Proligestone is a derivative of 17α-Hydroxy Progesterone, which is a metabolite of Progesterone, a steroid hormone produced by the corpus luteum. Proligestone maintains the ability to affect the hypothalmic-pituitary-adrenocortical axis and glucose homeostasis.
CAS:23887-41-4
Molecular Formula:C20H28N2O6
Alias
More Information
Cinepazet; {4-[(E)-3-(3,4,5-Trimethoxy-Phenyl)-Acryloyl]-Piperazin-1-Yl}-Acetic Acid Ethyl Ester; Unii-0Lc95Wwe9Q; 0Lc95Wwe9Q; Ethyl 2-[4-[(E)-3-(3,4,5-Trimethoxyphenyl)Prop-2-Enoyl]Piperazin-1-Yl]Acetate
Brief Introduction
Cineperate, western medicine name. The commonly used dosage form is injection. It is used for cerebrovascular diseases, cerebral arteriosclerosis, transient ischemic attack, cerebral thrombosis, cerebral embolism, postoperative recovery period of brain injury, sequelae of cerebral hemorrhage and sequelae of brain injury. Coronary heart disease and angina pectoris, if used for myocardial infarction, should be combined with relevant drug comprehensive treatment; It can also be used for peripheral vascular disease, such as lower extremity atherosclerosis, thromboangiitis obliterans, arteritis, Raynaud's disease, ophthalmology, Department of ENT disease, retinal arteriosclerosis, obstruction, ischemia induced ophthalmopathy, cochlear vestibular dysfunction caused by ischemia, sudden deafness, tinnitus, peripheral vascular disease caused by diabetes and microcirculation disturbance.
CAS:23930-19-0
Molecular Formula:C21H32O3
Alias
More Information
Alphaxalone; Cyclothiazide; Gr 2/234; 3Alpha-Hydroxy-5Alpha-Pregnane-11,20-Dione; 5Alpha-Pregnan-3Alpha-Ol-11,20-Dione; Alfaxalonum [Inn-Latin]
Brief Introduction
Alfaxalone (INN, JAN), also known as alphaxalone or alphaxolone (BAN), is a neuroactive steroid and general anaesthetic. It is used in veterinary practice under the trade name Alfaxan, and is licensed for use in both dogs and cats. Along with alfadolone, it is also one of the constituents of anesthetic drug mixture althesin.
Unlike some of its predecessors alfaxalone is not associated with histamine release and anaphylaxis.; A study 1987 found the primary mechanism for the anaesthetic action of alfaxalone to be modulation of neuronal cell membrane chloride ion transport, induced by binding of alfaxalone to GABAA cell surface receptors.
A 1994 study found that alfaxalone binds to a different region of this receptor than the benzodiazepines. These benzodiazepine-insensitive GABAA receptors are located extrasynaptically and are responsible for tonic inhibition. The occurrence of tonic GABAA inhibition coincides with the expression of relatively rare receptor subunits, particularly the α4, α6, and δ subunits, and as a rule of thumb, δ subunit-containing receptors are extrasynaptic.
Alfaxalone is metabolised rapidly in the liver. It has a very short plasma elimination half-life in dogs and cats.
CAS:239463-85-5
Molecular Formula:C26H31N3O8
Alias
More Information
(R)-5-(2-Aminopropyl)-1-(3-Benzoyloxypropyl) Indoline-7-Carbonitrile Tartaric Acid; 5-[(2R)-2-Aminopropyl]-1-[3-(Benzoyloxy)Propyl]-2,3-Dihydro-1H-Indole-7-Carbonitrile (2R,3R)-2,3-Dihydroxybutanedioate; (R)-3-(5-(2-Aminopropyl)-7-Cyanoindolin-1-Yl)Propyl Benzoate (2R,3R)-2,3-Dihydroxysuccinate; 3-{5[(2R)-2-Aminoprppyl]-7-Cyano-2,3-Dihydro-1H-Indol-1-Yl}Propyl Benzoate Monotartaric Acid Salt; 1-(3-Benzoyloxypropyl)-7-Cyano-5-(2-Aminopropyl)-2,3-Dihydroindole; 3-(5-((R)-2-Aminopropyl)-7-Cyanoindolin-1-Yl)Propyl Benzoate L-Tartrate
Brief Introduction
It can be used as an intermediate of cilodoxin.
CAS:23978-85-0
Molecular Formula:C22H30O4
Alias
More Information
6H-Dibenzo[B,D]Pyran-2-Carboxylic Acid, 6A,7,8,10A-Tetrahydro-1-Hydroxy-6,6,9-Trimethyl-3-Pentyl-, (6Ar,10Ar)-; 6H-Dibenzo[B,D]Pyran-2-Carboxylic Acid, 6Aβ,7,8,10Aα-Tetrahydro-1-Hydroxy-6,6,9-Trimethyl-3-Pentyl- (8Ci); (-)-Δ9-Trans-Tetrahydrocannabinolic Acid; Δ9-Thc-Carboxylic Acid; 6H-Dibenzo[B,D]Pyran-2-Carboxylic Acid, 6A,7,8,10A-Tetrahydro-1-Hydroxy-6,6,9-Trimethyl-3-Pentyl-, (6Ar-Trans)-; (6Ar,10Ar)-6A,7,8,10A-Tetrahydro-1-Hydroxy-6,6,9-Trimethyl-3-Pentyl-6H-Dibenzo[B,D]Pyran-2-Carboxylic Acid; Δ9-Tetrahydrocannabinolcarboxylic Acid; Tetrahydrocannabinolcarboxylic Acid; Cannabinolcarboxylic Acid, Δ9-Tetrahydro-; Tetrahydrocannabinol Acid; Δ9-Tetrahydrocannabinolic Acid; (-)-Trans-Δ9-Tetrahydrocannabinol Acid; Cannabinolic Acid A, Δ1-Tetrahydro-; Thca; Δ1-Tetrahydrocannabinolic Acid A; Δ9-Tetrahydrocannabinoic Acid A
Brief Introduction
Delta(9)-tetrahydrocannabinolic acid is a diterpenoid that is 6a,7,8,10a-tetrahydro-6H-benzo[c]chromene substituted at position 1 by a hydroxy group, positions 6, 6 and 9 by methyl groups and at position 3 by a pentyl group. A biosynthetic precursor to Delta(9)-tetrahydrocannabinol, the principal psychoactive constituent of the cannabis plant. It has a role as an anti-inflammatory agent, a neuroprotective agent, a biomarker and a metabolite. It is a diterpenoid, a benzochromene, a hydroxy monocarboxylic acid, a polyketide and a phytocannabinoid. It is a conjugate acid of a Delta(9)-tetrahydrocannabinolate.
Inquiry (
10
/ 10
)
Clear All
Sign In
Error!